Literature DB >> 7266019

Differences in uptake of adriamycin and daunomycin by normal BM cells and acute leukemia cell determined by flow cytometry.

P Sonneveld, G J van den Engh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7266019     DOI: 10.1016/0145-2126(81)90110-7

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  6 in total

1.  Kinetics and sensitivity of daunorubicin in patients with acute leukemia.

Authors:  M W DeGregorio; W M Holleran; B A Macher; C A Linker; J R Wilbur
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

2.  Uptake of adriamycin by human leukemic cells as measured by flow cytometry.

Authors:  H D Preisler; A Raza
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

3.  Uptake and metabolism of daunorubicin by human leukemia cells.

Authors:  M W DeGregorio; C J Carrera; J C Klock; J R Wilbur
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

4.  Quantitative evaluation of intracellular uptake of daunorubicin in acute myeloid leukemia: a method analysis.

Authors:  E Kokenberg; P Sonneveld; K Nooter; K van der Steuyt; B Löwenberg
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Effect of verapamil on daunorubicin accumulation in lymphocytes isolated from patients undergoing chemotherapy.

Authors:  A T McGown; D Murphy; D Crowther; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  Synthesis of a dual functional anti-MDR tumor agent PH II-7 with elucidations of anti-tumor effects and mechanisms.

Authors:  Ye Su; Xin Cheng; Yaohong Tan; Yunhui Hu; Yuan Zhou; Juanni Liu; Yuanfu Xu; Yinliang Xie; Caiyun Wang; Yingdai Gao; Jianxiang Wang; Tao Cheng; Chunzheng Yang; Dongsheng Xiong; Hua Miao
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.